» Authors » Cheng-Ting Tsai

Cheng-Ting Tsai

Explore the profile of Cheng-Ting Tsai including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 82
Citations 374
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Krischer J, Muller S, You L, Achenbach P, Bazzigaluppi E, Brigatti C, et al.
Diabetes . 2025 Mar; PMID: 40063422
This study compares novel type 1 diabetes-related autoantibody assays developed to improve upon the standard radiobinding assay (RBA). Samples from 1505 individuals, followed for 5 years or to clinical type...
2.
Hung T, Chien S, Tsao C, Wu Y, Yen C, Hsiao C, et al.
Int J Cardiol . 2025 Feb; 425:133064. PMID: 39952474
Background: Accumulating evidences have suggested a pathophysiological link between coronary microvascular dysfunction (CMD) and heart failure with preserved ejection fraction (HFpEF). The clinical relevance and prognostic impact of myocardial blood...
3.
Algadi I, AlRuthia Y, Mujammami M, Aburisheh K, Alotaibi M, Al Issa S, et al.
JMIR Res Protoc . 2025 Feb; PMID: 39930327
Background: Type 1 Diabetes (T1D) is a growing global health concern, with a notable rise in incidence in Saudi Arabia. Despite the potential benefits of early detection through screening programs,...
4.
Chien S, Lan W, Yun C, Sung K, Yeh H, Tsai C, et al.
Sci Rep . 2024 Oct; 14(1):25477. PMID: 39462060
Although several studies have demonstrated the cardiovascular (CV) implication of hypoalbuminemia and arterial calcification among hemodialysis patients, little is known regarding their cardiac correlates and relevant CV outcomes in asymptomatic...
5.
Ong P, Chui S, Chor-Cheung Tam F, Nguyen Q, Tsai C, Kang W, et al.
Catheter Cardiovasc Interv . 2024 Oct; 104(7):1406-1413. PMID: 39434554
Background: Patients undergoing primary percutaneous coronary intervention (PPCI) for ST-segment-elevation myocardial infarction (STEMI) have a high thrombotic burden and often have a high bleeding risk (HBR). Asian patients have different...
6.
Cheng J, Lee C, Chiang J, Liu S, Huang C, Liou J, et al.
Int J Obes (Lond) . 2024 Sep; 48(12):1767-1774. PMID: 39232101
Background: Obesity paradox addressing all-cause mortality has been described in several chronic total occlusion (CTO) studies. However, the impact of aging on long-term cardiac events in patients with overweight and...
7.
Liu S, Lee C, Cheng J, Chiang J, Tsai C, Chang C, et al.
Ann Med . 2024 Aug; 56(1):2396076. PMID: 39193705
Background: As the burden and distribution of calcification within chronic total occlusion (CTO) lesions can be diverse, its effect on CTO recanalization using multiple devices and techniques is debatable. This...
8.
Lin C, Lin S, Liao F, Lan W, Tsai C, Lee Y
Acta Cardiol Sin . 2024 Jul; 40(4):383-387. PMID: 39045378
Ojective: To understand hypertensive patients' preference for catheter-based therapy to manage hypertension. Methods: Survey data regarding catheter-based therapies performed at MacKay Memorial Hospital in Taipei, Taiwan, between 2019-2020 were analyzed....
9.
Lim E, Mehrotra M, Lamba K, Kamali A, Lai K, Meza E, et al.
BMC Med Res Methodol . 2024 May; 24(1):120. PMID: 38802749
Background: To describe the methodology for conducting the CalScope study, a remote, population-based survey launched by the California Department of Public Health (CDPH) to estimate SARS-CoV-2 seroprevalence and understand COVID-19...
10.
Lind A, Freyhult E, de Jesus Cortez F, Ramelius A, Bennet R, Robinson P, et al.
EBioMedicine . 2024 May; 104:105144. PMID: 38723553
Background: Two or more autoantibodies against either insulin (IAA), glutamic acid decarboxylase (GADA), islet antigen-2 (IA-2A) or zinc transporter 8 (ZnT8A) denote stage 1 (normoglycemia) or stage 2 (dysglycemia) type...